المؤلفون: Eduardo Magalhães Rego, Sarah Cristina Bassi

المصدر: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Revista Brasileira de Hematologia e Hemoterapia v.34 n.2 2012
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia, Volume: 34, Issue: 2, Pages: 134-139, Published: 2012
Revista Brasileira de Hematologia e Hemoterapia, Vol 34, Iss 2, Pp 134-139 (2012)

مصطلحات موضوعية: Acute promyelocytic leukemia, medicine.medical_treatment, leukemia, myeloid, acute, Retinoic acid, Leukemia, promyelocytic, acute/drug therapy, Immunofluorescence, Leukemia, myeloid, acute/diagnosis, Special Article, Leukemia, promyelocytic, acute/epidemilogy, chemistry.chemical_compound, Promyelocytic leukemia protein, Chromosome 15, medicine, leukemia, promyelocytic, acute/epidemilogy, Leukemia, promyelocytic, acute/diagnosis, leukemia, promyelocytic, acute/drug therapy, leukemia, myeloid, acute/drug therapy, leukemia, promyelocytic, acute, Leukemia, myeloid, acute/drug therapy, Chemotherapy, medicine.diagnostic_test, biology, lcsh:RC633-647.5, business.industry, leukemia, myeloid, acute/diagnosis, leukemia, myeloid, acute/epidemiology, lcsh:Diseases of the blood and blood-forming organs, Hematology, medicine.disease, Leukemia, myeloid, acute/epidemiology, chemistry, Retinoic acid receptor alpha, Immunology, biology.protein, Antibody, business, EPIDEMIOLOGIA, leukemia, promyelocytic, acute/diagnosis

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce2b7825c16d6dacb02cfa47f867e88cTest
https://doi.org/10.5581/1516-8484.20120033Test

المؤلفون: Odile Burlet-Schiltz, Bernard Monsarrat, Stéphane Manenti, Marie-Pierre Bousquet-Dubouch, Mariette Matondo, Christian Recher, Sandrine Uttenweiler-Joseph, Bernard Payrastre, Nathalie Gallay

المساهمون: Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Centre de Physiopathologie de Toulouse-Purpan (INSERM U563 - CNRS UMR1037), Centre National de la Recherche Scientifique (CNRS)-Centre de lutte contre le cancer (CLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Institut Claudius Regaud, This work was supported by the CNRS, by grants from the Fonds Sociaux Européens and the Ligue contre le Cancer (MM), and in part by grants from the Région Midi-Pyrénées and the Génopole Toulouse Midi-Pyrénées., The authors would like to thank Millennium Pharmaceuticals for their generous gift of bortezomib and are very grateful to Dr. C. Demur for helpful assistance in managing the patient samples used in this study.

المصدر: Leukemia Research
Leukemia Research, Elsevier, 2010, 34 (4), pp.498-506. ⟨10.1016/j.leukres.2009.09.020⟩

مصطلحات موضوعية: Proteomics, Male, Cancer Research, Leupeptins, MESH: Drug Resistance, Neoplasm / drug effects, MESH: Leukemia, Myeloid, Acute / metabolism, Apoptosis, MESH: Proteasome Endopeptidase Complex / metabolism, Proteasome regulators, Bortezomib, MESH: Aged, 80 and over, 0302 clinical medicine, Tumor Cells, Cultured, MESH: Bortezomib, MESH: Aged, Aged, 80 and over, MESH: Proteasome Endopeptidase Complex / analysis, 0303 health sciences, MESH: Middle Aged, MESH: Leukemia, Myeloid, Acute / pathology, U937 cell, Myeloid leukemia, U937 Cells, Hematology, Middle Aged, Cell cycle, Prognosis, Boronic Acids, 3. Good health, Leukemia, Myeloid, Acute, Oncology, Pyrazines, 030220 oncology & carcinogenesis, MESH: Pyrazines / pharmacology, Female, MESH: Daunorubicin / pharmacology, Proteasome Inhibitors, medicine.drug, Adult, Proteasome Endopeptidase Complex, MESH: Protease Inhibitors / pharmacology, Daunorubicin, Antineoplastic Agents, HL-60 Cells, MESH: U937 Cells, Biology, MESH: Prognosis, 03 medical and health sciences, MESH: Leukemia, Myeloid, Acute / diagnosis, MESH: Proteasome Inhibitors, MESH: Apoptosis / drug effects, MESH: HL-60 Cells, medicine, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Protease Inhibitors, MESH: Tumor Cells, Cultured, Aged, 030304 developmental biology, MESH: Humans, Mass spectrometry, MESH: Drug Resistance, Neoplasm / physiology, MESH: Leupeptins / pharmacology, MESH: Adult, MESH: Boronic Acids / pharmacology, 2D gel electrophoresis, MESH: Antineoplastic Agents / pharmacology, MESH: Male, 20S proteasome, Proteasome, Drug Resistance, Neoplasm, Proteasome inhibitor, Cancer research, MESH: Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c9c627ffc922f7fa4dfe1b585c758eTest
https://doi.org/10.1016/j.leukres.2009.09.020Test

المؤلفون: Ioannis Georgiou, Konstantinos L. Bourantas, Maria Syrrou, Eleftheria Hatzimichael, George Dranitsaris, Stavroula Tsiara, Aggeliki Dasoula, Leonidas Benetatos

المصدر: Leukemia Research. 34:148-153

مصطلحات موضوعية: Cancer Research, DNA Methylation, snRNP Core Proteins, Myelodysplastic Syndromes/diagnosis/*genetics/mortality, Genomic Imprinting, hemic and lymphatic diseases, medicine, Promoter Regions, Genetic, Leukemia, Myeloid, Acute/diagnosis/*genetics/mortality, Proteins/*genetics, MEG3, business.industry, Myelodysplastic syndromes, Proteins, Myeloid leukemia, Hematology, Methylation, Prognosis, medicine.disease, Survival Rate, Leukemia, Myeloid, Acute, Leukemia, Oncology, CpG site, Myelodysplastic Syndromes, DNA methylation, snRNP Core Proteins/*genetics, Cancer research, RNA, Long Noncoding, CpG Islands, business, Genomic imprinting

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f12a42ad769e61e1ed10cc452899f03Test
https://doi.org/10.1016/j.leukres.2009.06.019Test

المؤلفون: Fabio Rigamonti, Jakob Passweg, Photis Beris, Yves Chalandon, S. Zaza, G. Ashrafpoor, A. Sanchez-Pareja, Philippe Meyer

المصدر: International Journal of Hematology, Vol. 89, No 5 (2009) pp. 693-698

مصطلحات موضوعية: Male, Pathology, medicine.medical_specialty, Myeloid, Sarcoma, Myeloid/*diagnosis/drug therapy, Cardiomegaly, Heart Neoplasms/*diagnosis/drug therapy, Pericardial effusion, Immunophenotyping, Heart Neoplasms, Fatal Outcome, Humans, Medicine, Pericardium, Pleural Effusion/pathology, Sarcoma, Myeloid, ddc:616, Cardiac Myeloid Sarcoma, business.industry, Remission Induction, Myeloid leukemia, Hematology, Middle Aged, medicine.disease, Shock, Septic, Pleural Effusion, Leukemia, Myeloid, Acute, Leukemia, medicine.anatomical_structure, Bone marrow, Leukemia, Myeloid, Acute/*diagnosis/drug therapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8080eea2c013ca66ace05c3eb015780bTest
https://doi.org/10.1007/s12185-009-0313-6Test